MOLECULAR IMAGING AND BIOLOGY

Scope & Guideline

Exploring the Frontiers of Molecular Imaging and Biology

Introduction

Explore the comprehensive scope of MOLECULAR IMAGING AND BIOLOGY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore MOLECULAR IMAGING AND BIOLOGY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1536-1632
PublisherSPRINGER
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2002 to 2024
AbbreviationMOL IMAGING BIOL / Mol. Imaging. Biol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The journal "Molecular Imaging and Biology" focuses on advancing the field of molecular imaging, integrating various imaging modalities and biological applications to enhance diagnostic and therapeutic strategies in medicine. It encompasses a wide range of topics that bridge the gap between basic research and clinical applications.
  1. Molecular Imaging Techniques:
    The journal emphasizes the development and application of various molecular imaging techniques, including PET, MRI, CT, and optical imaging, to visualize biological processes at the molecular and cellular levels.
  2. Radiotracer Development:
    A core focus is on the design, synthesis, and validation of new radiotracers and imaging agents, particularly those targeting specific biological pathways or disease markers.
  3. Preclinical and Clinical Applications:
    The journal publishes research that translates preclinical findings into clinical practice, exploring how molecular imaging can guide diagnosis, treatment planning, and monitoring of various diseases.
  4. Theranostics:
    A significant area of interest involves theranostics, where imaging and therapy are combined, allowing for personalized treatment strategies based on imaging findings.
  5. Biomarkers and Disease Mechanisms:
    The journal aims to highlight studies that identify and validate imaging biomarkers associated with disease mechanisms, progression, and treatment response.
  6. Innovative Imaging Technologies:
    It also covers advancements in imaging technologies, such as hybrid imaging modalities and novel imaging probes, which enhance the sensitivity and specificity of imaging assessments.
The journal "Molecular Imaging and Biology" is witnessing exciting trends and emerging themes that reflect the dynamic nature of the field. Recent publications indicate a growing focus on innovative approaches and applications that enhance the capabilities of molecular imaging.
  1. Machine Learning and AI in Imaging:
    There is a significant increase in studies utilizing machine learning and artificial intelligence techniques to enhance image analysis, improve diagnostic accuracy, and predict treatment outcomes.
  2. Targeted Molecular Imaging Probes:
    Recent publications show a trend towards the development of highly specific targeted molecular imaging probes that can visualize particular cellular processes or disease states, enhancing the precision of diagnostic imaging.
  3. Theranostic Applications:
    The integration of imaging and therapeutic strategies (theranostics) is gaining momentum, with more studies exploring how imaging can guide therapy decisions and monitor treatment responses.
  4. Immuno-PET and Immuno-Oncology:
    There is a notable increase in research focusing on immuno-PET techniques and their applications in oncology, particularly for tracking immune responses and evaluating novel immunotherapeutic agents.
  5. Advancements in Hybrid Imaging Technologies:
    The rise of hybrid imaging technologies, combining modalities like PET/MRI and PET/CT, is becoming more prevalent, allowing for more comprehensive assessments of biological processes.
  6. Real-Time Imaging Techniques:
    Emerging studies are increasingly focusing on real-time imaging methods that enable dynamic monitoring of biological processes, particularly in the context of cancer treatment and cellular therapies.

Declining or Waning

While "Molecular Imaging and Biology" continues to thrive in many areas, certain themes appear to be experiencing a decline in frequency or prominence within recent publications. These waning scopes may reflect shifts in research focus or the maturation of specific methodologies.
  1. Traditional Imaging Modalities:
    There seems to be a reduction in the publication of studies solely focused on traditional imaging methods without the integration of molecular or biological insights, indicating a shift towards more advanced and hybrid approaches.
  2. Basic Imaging Methodologies:
    Research centered around basic imaging techniques, such as standard CT or MRI without molecular imaging applications, is becoming less common, as the field evolves towards more innovative and specific applications.
  3. Single-Modal Imaging Studies:
    The prevalence of studies focusing exclusively on single-modal imaging techniques is declining, as the field increasingly favors multimodal approaches that provide more comprehensive insights into biological processes.
  4. Conventional Radiomics:
    While radiomics remains a significant area, there is a noticeable shift away from conventional radiomics methodologies towards more integrated and machine learning-based approaches that enhance predictive modeling.
  5. Non-targeted Imaging Agents:
    The use of non-targeted imaging agents in preclinical and clinical studies appears to be decreasing, with a stronger emphasis on targeted agents that provide higher specificity and relevance to particular diseases.

Similar Journals

PROSTATE

Leading the charge in prostate health research.
Publisher: WILEYISSN: 0270-4137Frequency: 16 issues/year

PROSTATE is a premier, peer-reviewed journal published by Wiley, focusing on the critical fields of urology and oncology. With an established history since 1980 and a projected convergence through 2024, this influential journal serves as a vital resource for researchers, clinicians, and students alike. It holds a prestigious position in the academic landscape, classified in the Q1 category for Urology and Q2 in Oncology as of 2023, demonstrating its significant contribution to these disciplines. With a Scopus rank of #23 in Urology and #169 in Oncology, PROSTATE is pivotal for advancing knowledge and fostering innovation in prostate research, treatment, and overall male health. The journal aims to publish high-quality original articles, reviews, and clinical studies that address the complexities of prostate-related conditions, ultimately seeking to improve patient outcomes and propagate best practices in the medical community.

Abdominal Radiology

Pioneering Insights for Abdominal Health
Publisher: SPRINGERISSN: 2366-004XFrequency: 12 issues/year

Abdominal Radiology is an esteemed journal published by Springer, focusing on the intricate and evolving field of abdominal imaging. With its ISSN 2366-004X and E-ISSN 2366-0058, this journal serves as a vital platform for disseminating high-quality research and clinical findings that advance both the understanding and practice of radiology specifically related to abdominal diseases. With a commendable impact, categorized in 2023 as Q2 in the fields of Gastroenterology, Radiological and Ultrasound Technology, and Radiology, Nuclear Medicine and Imaging, and Q1 in Urology, it attracts an audience eager for cutting-edge insights. Furthermore, its ranking in Scopus reflects its strong influence, with a notable position of #21 in Urology and #92 in Radiology. The journal adopts an Open Access model, facilitating a wider dissemination of knowledge and promoting collaborative research efforts on a global scale. The convergence of contributions from established researchers and emerging professionals alike enriches its content from 2016 to 2024, ensuring that readers remain at the forefront of abdominal diagnostics and therapeutic advancements.

ONCOLOGY RESEARCH

Exploring Innovative Strategies for Cancer Treatment
Publisher: TECH SCIENCE PRESSISSN: 0965-0407Frequency: 6 issues/year

ONCOLOGY RESEARCH, published by TECH SCIENCE PRESS, is a vital academic journal dedicated to the rapidly evolving field of oncology. With its ISSN 0965-0407 and E-ISSN 1555-3906, the journal serves as a key resource for researchers, clinicians, and academicians committed to advancing cancer research and treatment strategies. Operating without an Open Access model, ONCOLOGY RESEARCH provides high-quality, peer-reviewed articles that cover diverse topics within cancer research, medicine, and oncology, with its 2023 Scopus ranking placing it in the Q3 quartile. The journal's commitment to facilitating rigorous scientific discourse is evident in its historical breadth, with a publishing history dating back to 1992. ONCOLOGY RESEARCH is not only significant for the academic community but also plays a critical role in fostering new insights and approaches in the fight against cancer, making it a must-read for those involved in this critical area of study.

ACTA HISTOCHEMICA

Unveiling the Secrets of Cells with Cutting-Edge Histochemistry
Publisher: ELSEVIER GMBHISSN: 0065-1281Frequency: 8 issues/year

ACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.

BIOLOGICAL PROCEDURES ONLINE

Connecting Scholars Through Cutting-Edge Biological Insights.
Publisher: BMCISSN: Frequency: 1 issue/year

BIOLOGICAL PROCEDURES ONLINE is a premier open-access journal published by BMC, dedicated to advancing the fields of biochemistry, genetics, and molecular biology. With its electronic ISSN 1480-9222 and a strong commitment to accessibility since 2009, this journal provides a vital platform for researchers and scholars to disseminate their findings and foster collaboration within the scientific community. Based in the United Kingdom, this journal has garnered an impressive reputation, achieving Q1 status in the 2023 category rankings, with notable inclusion in the Scopus rankings, placing it in the 86th percentile among 221 peer journals in the general biochemistry, genetics, and molecular biology domain. It covers a broad range of topics, ensuring coverage of the latest advancements and methodologies in biological procedures, making it an essential resource for academics, practitioners, and students alike. Researchers are encouraged to submit their innovative work and contribute to the ongoing dialogue in this dynamic and ever-evolving field.

Molecular Imaging

Unveiling the Secrets of Molecular Structures.
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

Molecular Imaging is a prominent journal published by SAGE Publications Inc., which serves as a vital platform for the dissemination of high-quality research in the field of molecular imaging. With an E-ISSN of 1536-0121, this journal has established itself within several key areas, including Biomedical Engineering, Biotechnology, Condensed Matter Physics, Molecular Medicine, and Radiology, Nuclear Medicine and Imaging. Spanning from 2002 to 2024 and currently classified within the prestigious Q2 and Q3 quartiles, Molecular Imaging aims to highlight the latest developments and innovative methodologies in molecular imaging techniques and applications. Researchers from diverse backgrounds will find the journal's content valuable for staying updated with recent advancements, evidenced by its competitive Scopus ranking and a commitment to fostering interdisciplinary collaboration. Although the journal is not open access, the rigorous peer-review process ensures that all published articles provide significant contributions to the field, making it an essential resource for professionals, researchers, and students alike.

European Journal of Hybrid Imaging

Bridging Disciplines Through Hybrid Imaging Insights
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

European Journal of Hybrid Imaging, published by SpringerNature, stands as a pivotal platform for scholarly discourse in the rapidly evolving fields of hybrid imaging technologies and methodologies. Since its inception in 2017, this open access journal has significantly contributed to the interdisciplinary interface of biophysics, computer science, molecular medicine, and radiology. With its current standing in the Q2 and Q3 quartiles across various categories, it provides valuable insights and research outputs pertinent to both academic and clinical practitioners. The journal's rigorous peer-review process ensures the highest standards of scholarly integrity, while its open access format promotes global accessibility and encourages collaborative research efforts. Covering a diverse range of topics pertinent to hybrid imaging, the journal serves as an essential resource for researchers, professionals, and students alike, fostering innovation and knowledge exchange within the scientific community.

MOLECULAR CANCER RESEARCH

Pioneering Discoveries in Cancer Mechanisms
Publisher: AMER ASSOC CANCER RESEARCHISSN: 1541-7786Frequency: 12 issues/year

MOLECULAR CANCER RESEARCH, published by the American Association for Cancer Research, stands as a pivotal journal in the fields of cancer research, molecular biology, and oncology. With an impressive impact factor and recognized as a Q1 journal in its respective categories for 2023, it serves as an essential resource for researchers, professionals, and students aimed at advancing our understanding of cancer mechanisms and therapies. The journal, identified by the ISSN 1541-7786 and E-ISSN 1557-3125, provides a platform for cutting-edge research and clinical applications, emphasizing innovation and collaboration within the scientific community. With its focus on high-quality, peer-reviewed articles, MOLECULAR CANCER RESEARCH is vital for anyone looking to stay abreast of significant advancements in cancer biology and treatment strategies. For more details and to access the journal's content, please visit the publisher's link.

Current Radiology Reports

Elevating clinical practice through innovative radiology reports.
Publisher: SPRINGERNATUREISSN: Frequency: 12 issues/year

Current Radiology Reports is an esteemed journal published by SPRINGERNATURE, focusing on the dynamic field of radiology, nuclear medicine, and imaging. With a commitment to advancing knowledge and promoting innovative practices, this journal serves as a valuable resource for researchers, healthcare professionals, and students striving to stay at the forefront of radiological advancements. Featuring an impressive impact factor and recognized as a Q3 journal within its category as of 2023, it highlights critical developments and comprehensive reviews that inform clinical practice and research methodologies. Although it operates under a subscription model, the journal provides a rich repository of peer-reviewed content, covering a wide range of topics from diagnostic imaging to therapeutic applications. With a publication span from 2013 to 2024, Current Radiology Reports continues to uphold its reputation as a leading publication critical for anyone involved in the radiology profession.

NMR IN BIOMEDICINE

Charting New Territories in NMR and Biomedical Applications
Publisher: WILEYISSN: 0952-3480Frequency: 12 issues/year

NMR in Biomedicine is a prestigious journal published by Wiley that has been at the forefront of advancing research in the integration of Nuclear Magnetic Resonance (NMR) techniques within the realms of biomedicine since its establishment in 1988. With its ISSN 0952-3480 and E-ISSN 1099-1492, this journal focuses on the application of NMR across various scientific disciplines, including Molecular Medicine, Radiology, Nuclear Medicine and Imaging, and Spectroscopy. The journal is classified in the Q1 and Q2 quartiles as of 2023, showcasing its significant impact and contribution, particularly in Radiology and Spectroscopy, where it ranks in the top tier of its fields. The Scopus ranks reflect its esteemed position, with notable placements such as #70/333 in Radiology and #25/76 in Chemistry Spectroscopy. While Open Access options are not available, the journal remains committed to providing high-quality, peer-reviewed research that fosters innovation and collaboration within the scientific community. Researchers, professionals, and students are encouraged to explore the cutting-edge findings presented in this journal, as it continues to shape the future of biomedical applications of NMR.